NCT05793502View on ClinicalTrials.gov

Study on Effectiveness and Safety of LBBaP With Solia S and Selectra 3D Developed by BIOTRONIK

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

April 20, 2025

Study Completion Date

April 20, 2025

Conditions
Consented to Participate in the Trial and Signed an ICFPatients With an Indication for PM Implantation or CRTP
Interventions
DEVICE

Solia S and Selectra 3D Developed by BIOTRONIK

LBBaP with Solia S and Selectra 3D Developed by BIOTRONIK

Trial Locations (1)

Unknown

RECRUITING

Shanxi Cardiovascular Hospital, Taiyuan

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER